Physicians’ Attitudes Toward Prescribable mHealth Apps and Implications for Adoption in Germany: Mixed Methods Study
BackgroundIn October 2020, Germany became the first country, worldwide, to approve certain mobile health (mHealth) apps, referred to as DiGA (Digitale Gesundheitsanwendungen, in German, meaning digital health applications), for prescription with costs covered by standard stat...
Main Authors: | Florian Dahlhausen, Maximillian Zinner, Linn Bieske, Jan P Ehlers, Philip Boehme, Leonard Fehring |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2021-11-01
|
Series: | JMIR mHealth and uHealth |
Online Access: | https://mhealth.jmir.org/2021/11/e33012 |
Similar Items
-
There's an app for that, but nobody's using it: Insights on improving patient access and adherence to digital therapeutics in Germany
by: Florian Dahlhausen, et al.
Published: (2022-07-01) -
Rating analysis and BERTopic modeling of consumer versus regulated mHealth app reviews in Germany
by: Marie Uncovska, et al.
Published: (2023-06-01) -
Evidence of How Physicians and Their Patients Adopt mHealth Apps in Germany: Exploratory Qualitative Study
by: Tanja Schroeder, et al.
Published: (2024-01-01) -
Perspective of German medical faculties on digitization in the healthcare sector and its influence on the curriculum
by: Neumann, Maximilian, et al.
Published: (2021-11-01) -
Prescribable mHealth apps identified from an overview of systematic reviews
by: Oyungerel Byambasuren, et al.
Published: (2018-05-01)